PURNA SHARMA
Allopathic & Osteopathic Physicians|Internal Medicine SEAFORD, DE NPI 1902391675
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine DE Lilly USA, LLC All categories
General Payments — all program years on this page
$3,540.76
- Category: General Payments
- Program years: PY2019–2024
- Record count: 188
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,354.98 across 72 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,354.98 | 72 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $169.23 | 11 |
| ABBVIE INC. | $153.97 | 12 |
| Mallinckrodt Hospital Products Inc. | $132.07 | 5 |
| Lundbeck LLC | $111.25 | 4 |
| Novo Nordisk AS | $109.41 | 6 |
| EISAI INC. | $98.39 | 5 |
| Merck Sharp & Dohme Corporation | $66.40 | 2 |
| Acerta Pharma LLC | $54.05 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $53.87 | 3 |
| GENZYME CORPORATION | $49.34 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $47.06 | 3 |
| SANOFI-AVENTIS U.S. LLC | $41.30 | 2 |
| PFIZER INC. | $40.82 | 2 |
| GlaxoSmithKline, LLC. | $39.12 | 2 |
| SHIELD THERAPEUTICS INC | $24.98 | 1 |
| Exact Sciences Corporation | $24.78 | 1 |
| UCB, Inc. | $24.07 | 1 |
| Insulet Corporation | $19.23 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $19.04 | 1 |
| Neurelis, Inc. | $19.02 | 1 |
| Amgen Inc. | $15.99 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.06 | 1 |
| Electromed, Inc. | $13.80 | 1 |
| Pharming Healthcare, Inc. | $13.73 | 1 |
By program year
Records — PY2024 (72)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.